Setting the course for apoAII: a port in sight?

References

• Havel RJ, Goldstein JL, Brown MS. Lipoproteins and lipid transport. In: The Metabolic Control of Disease. Bondy PK, Rosenberg LE (Eds). Saunders Publishing, PA, USA, 398–494 (1980).
   Google Scholar
• Gofman JW, Young W, Tandy R. Ischemic heart disease, atherosclerosis, and longevity. Circulation 34(4), 679–697 (1966).
   Google Scholar
• Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 8(6), 737–741 (1988).
   Google Scholar
• Glomset JA, Parker F, Tjaden M, Williams RH. The esterification in vitro of free cholesterol in human and rat plasma. Biochim. Biophys. Acta 58, 398–406 (1962).
   Google Scholar
• Glomset JA. The plasma lecithins:cholesterol acyltransferase reaction. J. Lipid Res. 9(2), 155–167 (1968).
   Google Scholar
• Rosenson RS, Brewer HB Jr, Davidson WS et al. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 125(15), 1905–1919 (2012).
   Google Scholar
• Mendez AJ, Anantharamaiah GM, Segrest JP, Oram JF. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J. Clin. Invest. 94(4), 1698–1705 (1994).
   Google Scholar
• Fielding CJ, Shore VG, Fielding PE. A protein cofactor of lecithin:cholesterol acyltransferase. Biochem. Biophys. Res. Commun. 46(4), 1493–1498 (1972).
   Google Scholar
• Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Anti-inflammatory properties of HDL. Circ. Res. 95(8), 764–772 (2004).
   Google Scholar
• Yamashita J, Iwamura C, Sasaki T et al. Apolipoprotein A-II suppressed concanavalin A-induced hepatitis via the inhibition of CD4 T cell function. J. Immunol. 186(6), 3410–3420 (2011).
   Google Scholar
• Shore B, Shore V. Heterogeneity in protein subunits of human serum high-density lipoproteins. Biochemistry 7(8), 2773–2777 (1968).
   Google Scholar
• Lux SE, John KM, Brewer HB Jr. Isolation and characterization of apoLp-Gln-II (apoA-II), a plasma high density apolipoprotein containing two identical polypeptide chains. J. Biol. Chem. 247(23), 7510–7518 (1972).
   Google Scholar
• Li WH, Tanimura M, Luo CC, Datta S, Chan L. The apolipoprotein multigene family: biosynthesis, structure, structure–function relationships, and evolution. J. Lipid Res. 29(3), 245–271 (1988).
   Google Scholar
• Byrne RE, Polacek D, Gordon JI, Scanu AM. The enzyme that cleaves apolipoprotein A-II upon in vitro incubation of human plasma high-density lipoprotein-3 with blood polymorphonuclear cells is an elastase. J. Biol. Chem. 259(23), 14537–14543 (1984).
   Google Scholar
• Davidson WS, Silva RA. Apolipoprotein structural organization in high density lipoproteins: belts, bundles, hinges and hairpins. Curr. Opin. Lipidol. 16(3), 295–300 (2005).
   Google Scholar
• Silva RA, Schneeweis LA, Krishnan SC, Zhang X, Axelsen PH, Davidson WS. The structure of apolipoprotein A-II in discoidal high density lipoproteins. J. Biol. Chem. 282(13), 9713–9721 (2007).
   Google Scholar
• Birjmohun RS, Dallinga-Thie GM, Kuivenhoven JA et al. Apolipoprotein A-II is inversely associated with risk of future coronary artery disease. Circulation 116(18), 2029–2035 (2007).
   Google Scholar
• Blanco-Vaca F, Via DP, Yang CY, Massey JB, Pownall HJ. Characterization of disulfide-linked heterodimers containing apolipoprotein D in human plasma lipoproteins. J. Lipid Res. 33(12), 1785–1796 (1992).
   Google Scholar
• Weisgraber KH, Shinto LH. Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity. J. Biol. Chem. 266(18), 12029–12034 (1991).
   Google Scholar
• Cheung MC, Albers JJ. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J. Biol. Chem. 259(19), 12201–12209 (1984).
   Google Scholar
• Lund-Katz S, Murley YM, Yon E, Gillotte KL, Davidson WS. Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles. Lipids 31(11), 1107–1113 (1996).
   Google Scholar
• Edelstein C, Halari M, Scanu AM. On the mechanism of the displacement of apolipoprotein A-I by apolipoprotein A-II from the high density lipoprotein surface. Effect of concentration and molecular forms of apolipoprotein A-II. J. Biol. Chem. 257(12), 7189–7195 (1982).
   Google Scholar
• Pownall HJ, Hickson D, Gotto AM Jr. Thermodynamics of lipid-protein association. The free energy of association of lecithin with reduced and carboxymethylated apolipoprotein A-II from human plasma high density lipoprotein. J. Biol. Chem. 256(19), 9849–9854 (1981).
   Google Scholar
• Marzal-Casacuberta A, Blanco-Vaca F, Ishida BY et al. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II. J. Biol. Chem. 271(12), 6720–6728 (1996).
   Google Scholar
• Hussain MM, Zannis VI. Intracellular modification of human apolipoprotein AII (apoAII) and sites of apoAII mRNA synthesis: comparison of apoAII with apoCII and apoCIII isoproteins. Biochemistry 29(1), 209–217 (1990).
   Google Scholar
• Bossu JP, Chartier FL, Vu-Dac N, Fruchart JC, Laine B. Transcription of the human apolipoprotein A-II is down-regulated by the first intron of its gene. Biochem. Biophys. Res. Commun. 202(2), 822–829 (1994).
   Google Scholar
• Vu-Dac N, Schoonjans K, Kosykh V et al. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J. Clin. Invest. 96(2), 741–750 (1995).
   Google Scholar
• Vu-Dac N, Schoonjans K, Kosykh V et al. Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor. Mol. Cell Biol. 16(7), 3350–3360 (1996).
   Google Scholar
• Ikewaki K, Zech LA, Kindt M, Brewer HB Jr, Rader DJ. Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans. Arterioscler. Thromb. Vasc. Biol. 15(3), 306–312 (1995).
   Google Scholar
• Chisholm JW, Burleson ER, Shelness GS, Parks JS. ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL. J. Lipid Res. 43(1), 36–44 (2002).
   Google Scholar
• Gillard BK, Lin HY, Massey JB, Pownall HJ. Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells. Biochim. Biophys. Acta 1791(12), 1125–1132 (2009). ▪ Demonstrates that apoAII occurs on HDL particles that have no apoAI, and that hepatically derived factors catalyze fusion of apoAII‑containing particles with those containing apoAI.
   Google Scholar
• Maric J, Kiss RS, Franklin V, Marcel YL. Intracellular lipidation of newly synthesized apolipoprotein A-I in primary murine hepatocytes. J. Biol. Chem. 280(48), 39942–39949 (2005).
   Google Scholar
• Gillard BK, Chen YS, Gaubatz JW, Massey JB, Pownall HJ. Plasma factors required for human apolipoprotein A-II dimerization. Biochemistry 44(2), 471–479 (2005).
   Google Scholar
• Massey JB, Pownall HJ. Cholesterol is a determinant of the structures of discoidal high density lipoproteins formed by the solubilization of phospholipid membranes by apolipoprotein A-I. Biochim. Biophys. Acta 1781(5), 245–253 (2008).
   Google Scholar
• Bassett GR, Gillard BK, Pownall HJ. Cholesterol determines and limits rHDL formation from human plasma apolipoprotein A-II and phospholipid membranes. Biochemistry 51(43), 8627–8635 (2012). ▪ Demonstrates that the free cholesterol content of membranes determines the size of reconstituted HDL particles formed by microsolubilization; increased free cholesterol in membranes leads to an increase in the size of reconstituted HDL.
   Google Scholar
• Shepherd J, Packard CJ, Gotto AM Jr, Taunton OD. A comparison of two methods to investigate the metabolism of human apolipoproteins A-I and and A-II. J. Lipid Res. 19(5), 656–661 (1978).
   Google Scholar
• Mehta R, Gantz DL, Gursky O. Human plasma high-density lipoproteins are stabilized by kinetic factors. J. Mol. Biol. 328(1), 183–192 (2003). ▪▪ Reveals, by a variety of physicochemical methods, that plasma HDL particles reside in a high‑energy kinetic trap from which they escape by chemical perturbations, which emulate the effects of plasma enzymes and transfer proteins.
   Google Scholar
• Rye KA, Hime NJ, Barter PJ. Evidence that cholesteryl ester transfer protein-mediated reductions in reconstituted high density lipoprotein size involve particle fusion. J. Biol. Chem. 272(7), 3953–3960 (1997).
   Google Scholar
• Lusa S, Jauhiainen M, Metso J, Somerharju P, Ehnholm C. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Biochem. J. 313(Pt 1), 275–282 (1996).
   Google Scholar
• Liang HQ, Rye KA, Barter PJ. Remodelling of reconstituted high density lipoproteins by lecithin: cholesterol acyltransferase. J. Lipid Res. 37(9), 1962–1970 (1996).
   Google Scholar
• Clay MA, Newnham HH, Barter PJ. Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high density lipoproteins during incubation in vitro. Arterioscler. Thromb. 11(2), 415–422 (1991).
   Google Scholar
• Gillard BK, Courtney HS, Massey JB, Pownall HJ. Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption. Biochemistry 46(45), 12968–12978 (2007). ▪▪ Demonstrates that a bacterial protein, serum opacity factor, catalyzes the escape of HDL from a kinetic trap, thereby forming a large cholesteryl ester‑rich particle, a small cholesterol‑deficient HDL and lipid‑free apoAI.
   Google Scholar
• Remaley AT, Stonik JA, Demosky SJ et al. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem. Biophys. Res. Commun. 280(3), 818–823 (2001).
   Google Scholar
• Miller NE. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am. Heart J. 113(2 Pt 2), 589–597 (1987).
   Google Scholar
• Deeb SS, Takata K, Peng RL, Kajiyama G, Albers JJ. A splice-junction mutation responsible for familial apolipoprotein A-II deficiency. Am. J. Hum. Genet. 46(4), 822–827 (1990).
   Google Scholar
• Schultz JR, Verstuyft JG, Gong EL, Nichols AV, Rubin EM. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature 365(6448), 762–764 (1993).
   Google Scholar
• Schultz JR, Rubin EM. The properties of HDL in genetically engineered mice. Curr. Opin. Lipidol. 5(2), 126–137 (1994).
   Google Scholar
• Tailleux A, Bouly M, Luc G et al. Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice. Arterioscler. Thromb. Vasc. Biol. 20(11), 2453–2458 (2000).
   Google Scholar
• Remaley AT. Apolipoprotein A-II: still second fiddle in high-density lipoprotein metabolism? Arterioscler. Thromb. Vasc. Biol. 33(2), 166–167 (2013).
   Google Scholar
• Koike T, Kitajima S, Yu Y et al. Expression of human apoAII in transgenic rabbits leads to dyslipidemia: a new model for combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 29(12), 2047–2053 (2009).
   Google Scholar
• Escola-Gil JC, Julve J, Marzal-Casacuberta A, Ordonez-Llanos J, Gonzalez-Sastre F, Blanco-Vaca F. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia. J. Lipid Res. 41(8), 1328–1338 (2000).
   Google Scholar
• Wang Y, Niimi M, Nishijima K et al. Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits. Arterioscler. Thromb. Vasc. Biol. 33(2), 224–231 (2013). ▪▪ According to this paper, transgenic expression of apoAII in rabbits, which do not naturally express apoAII, induces profound reduction in almost every measure of atherosclerosis.
   Google Scholar
• Hedrick CC, Lusis AJ. Apolipoprotein A-II: a protein in search of a function. Can. J. Cardiol. 10(4), 453–459 (1994).
   Google Scholar
• Blanco-Vaca F, Escola-Gil JC, Martin-Campos JM, Julve J. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. J. Lipid Res. 42(11), 1727–1739 (2001).
   Google Scholar
• Nissen SE, Tsunoda T, Tuzcu EM et al. Effect of recombinant apoA-Imilano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290(17), 2292–2300 (2003).
   Google Scholar
• Nicholls SJ, Tuzcu EM, Sipahi I et al. Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-Imilano. J. Am. Coll. Cardiol. 47(5), 992–997 (2006).
   Google Scholar
• Tardif JC, Gregoire J, L’Allier PL et al. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA 297(15), 1675–1682 (2007).
   Google Scholar
• Lackner KJ, Law SW, Brewer HB Jr. The human apolipoprotein A-II gene: complete nucleic acid sequence and genomic organization. Nucleic Acids Res. 13(12), 4597–4608 (1985).
   Google Scholar
• Jackson RL, Gotto AM Jr, Lux SE, John KM, Fleischer S. Human plasma high density lipoprotein. Interaction of the cyanogen bromide fragments from apolipoprotein glutamine II (A-II) with phosphatidylcholine. J. Biol. Chem. 248(24), 8449–8456 (1973).
   Google Scholar
• Mao SJ, Sparrow JT, Gilliam EB, Gotto AM Jr, Jackson RL. Mechanism of lipid-protein interaction in the plasma lipoproteins: lipid-binding properties of synthetic fragments of apolipoprotein A-II. Biochemistry 16(19), 4150–4156 (1977).
   Google Scholar
• Pownall HJ, Gotto AM Jr, Knapp RD, Massey JB. The helical hydrophobic moment avoids prolines in phospholipid-binding proteins. Biochem. Biophys. Res. Commun. 139(1), 202–208 (1986).
   Google Scholar